Germany-based Insightec and Israel-based Siemens Healthineers entered into a strategic agreement to develop compatibility between Insightec's Exablate Neuro device and Siemans' clinical MRI systems.

Insightec reaffirms its position at the forefront of the medical technology industry with improved functionality, safety features, and efficiency to its flagship product, setting new benchmarks in the ...

Positive momentum continues to bring Focused Ultrasound to global patients living with Essential Tremor and Tremor-dominant Parkinson's Disease HAIFA, Israel and MIAMI, July 5, 2021 /PRNewswire/ -- ...

While Insightec has raked in hundreds of millions of dollars in VC funding in recent years based largely on the strength of its Exablate Neuro platform, the company continues to expand its focused ...

HAIFA, Israel and MIAMI, Fla., Dec. 1, 2021 /PRNewswire/ -- Insightec, a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy, ...

HAIFA, Israel and MIAMI, July 8, 2025 /CNW/ -- Insightec, a global healthcare innovator dedicated to using focused ultrasound to transform patient care, announced today that the U.S. Food and Drug ...

The US Food and Drug Administration (FDA) has approved InSightec Ltd.'s ExAblate MRI-guided focused ultrasound as a therapy to treat pain from bone metastases in patients who do not respond or cannot ...

Philips' MRI scanners are now compatible with Insightec technology to treat patients suffering with essential tremor (ET) and Parkinson's disease. Exablate Prime is able to be integrated with select, ...